Dr. Paul Solomon is a founder and Clinical Director of the Boston Center for Memory specializing in Clinical Neuropsychology and neuroscience. He is a professor in the Department of Neurology at Boston University School of Medicine and an investigator at Boston University Alzheimer's Disease Center. Dr. Solomon is Professor Emeritus at Williams College in Williamstown, MA. He founded the neuroscience program at Williams College.
He is the founder and former Clinical Director of the Memory Clinic in Bennington, Vermont, and President of Clinical Neuroscience Research Associates. He has served as the first Director of Training for the Southwestern Vermont Psychology Consortium. He is currently Professor of Psychology and founding Chairman of the Neuroscience Program at Williams College.
Dr. Solomon was a lead investigator on the clinical trials for Cognex, the first drug approved for the treatment of Alzheimer’s disease in 1994. He was an author on the paper published in the Journal of the American Medical Association that served as the basis for the FDA approval of the drug. Since that time he has served as a principle investigator on more than 200 clinical trials in Mild Cognitive Impairment, Alzheimer’s disease and related dementias and served as an investigator of trials that led to the FDA approval of the 4 approved medications available to treat Alzheimer's disease. He also was an investigator of the trials that led to the approval of the PET amyloid scan.
Dr. Solomon has received a numerous awards including a Distinguished Teaching Award from the University of Massachusetts, a National Research Service Award from the National Institutes of Health, and a National Needs Postdoctoral Fellowship from the National Science Foundation, and a clinical research award from the American Association of Family Physicians. He has been elected as a Fellow of the American Association for the Advancement of Science, the American Psychological Association and the American Psychological Society. He is listed in Who’s Who in America, American Men and Women of Science, Who’s Who in Education, and Who’s Who in Frontier Science and Technology. Dr. Solomon has served on the Editorial Board of several journals and serves as an external reviewer for numerous journals and granting agencies. He has lectured widely at colleges and universities on age-related memory disorders and at medical centers and hospitals on the diagnosis and treatment of Alzheimer’s disease. Dr. Solomon has also appeared frequently to discuss pharmacotherapy for Alzheimer’s disease on national television including The Today Show, Good Morning America, The CBS Morning Show, and CBS, ABC, and NBC Evening News. His work on screening for Alzheimer ’s disease has been featured on Dateline NBC.
Dr. Solomon received his Ph.D. in Psychology from the University of Massachusetts Amherst. He was a postdoctoral fellow in the Laboratory of Richard F. Thompson in Department of Psychobiology at the University of California at Irvine. He is the author of several books, has also contributed chapters to 20 edited volumes, and has co-authored and presented more than 200 research papers. His work has been published in Science, Scientific American, Journal of the American Medical Association, and Lancet. He has delivered more than 500 invited colloquia, symposia, grand rounds, lectures, and presentations. He has been the recipient of research grants from the National Science Foundation, The National Institute on Aging, The National Institute of Mental Health, The United States Environmental Protection Agency, as well as private foundations and pharmaceutical research divisions.
Dr. Paul Solomon is a founder and Clinical Director of the Boston Center for Memory specializing in Clinical Neuropsychology and neuroscience. He is a professor in the Department of Neurology at Boston University School of Medicine and an investigator at Boston University Alzheimer's Disease Center. Dr. Solomon is Professor Emeritus at Williams College in Williamstown, MA. He founded the neuroscience program at Williams College.
He is the founder and former Clinical Director of the Memory Clinic in Bennington, Vermont, and President of Clinical Neuroscience Research Associates. He has served as the first Director of Training for the Southwestern Vermont Psychology Consortium. He is currently Professor of Psychology and founding Chairman of the Neuroscience Program at Williams College.
Dr. Solomon was a lead investigator on the clinical trials for Cognex, the first drug approved for the treatment of Alzheimer’s disease in 1994. He was an author on the paper published in the Journal of the American Medical Association that served as the basis for the FDA approval of the drug. Since that time he has served as a principle investigator on more than 200 clinical trials in Mild Cognitive Impairment, Alzheimer’s disease and related dementias and served as an investigator of trials that led to the FDA approval of the 4 approved medications available to treat Alzheimer's disease. He also was an investigator of the trials that led to the approval of the PET amyloid scan.
Dr. Solomon has received a numerous awards including a Distinguished Teaching Award from the University of Massachusetts, a National Research Service Award from the National Institutes of Health, and a National Needs Postdoctoral Fellowship from the National Science Foundation, and a clinical research award from the American Association of Family Physicians. He has been elected as a Fellow of the American Association for the Advancement of Science, the American Psychological Association and the American Psychological Society. He is listed in Who’s Who in America, American Men and Women of Science, Who’s Who in Education, and Who’s Who in Frontier Science and Technology. Dr. Solomon has served on the Editorial Board of several journals and serves as an external reviewer for numerous journals and granting agencies.
He has lectured widely at colleges and universities on age-related memory disorders and at medical centers and hospitals on the diagnosis and treatment of Alzheimer’s disease. Dr. Solomon has also appeared frequently to discuss pharmacotherapy for Alzheimer’s disease on national television including The Today Show, Good Morning America, The CBS Morning Show, and CBS, ABC, and NBC Evening News. His work on screening for Alzheimer ’s disease has been featured on Dateline NBC.
Dr. Solomon received his Ph.D. in Psychology from the University of Massachusetts Amherst. He was a postdoctoral fellow in the Laboratory of Richard F. Thompson in Department of Psychobiology at the University of California at Irvine. He is the author of several books, has also contributed chapters to 20 edited volumes, and has co-authored and presented more than 200 research papers. His work has been published in Science, Scientific American, Journal of the American Medical Association, and Lancet. He has delivered more than 500 invited colloquia, symposia, grand rounds, lectures, and presentations. He has been the recipient of research grants from the National Science Foundation, The National Institute on Aging, The National Institute of Mental Health, The United States Environmental Protection Agency, as well as private foundations and pharmaceutical research divisions.
